Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-n-(6-(4-isopropyl-4h-1,2,4-triazol-3-yl)-2-pyridinyl)-4-methylbenzamide
2. Benzamide, 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-(6-(4-(1-methylethyl)-4h-1,2,4-triazol-3-yl)-2-pyridinyl)-
1. 1448428-04-3
2. Gs-4997
3. Selonsertib [inn]
4. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-n-(6-(4-isopropyl-4h-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide
5. Selonsertib(gs-4997)
6. 5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-n-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide
7. Gs 4997
8. Ns3988a2tc
9. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-{6-[4-(propan-2-yl)-4h-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide
10. Gs-4997; Gs4997; Gs 4997; Selonsertib Free Base ;5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-n-(6-(4-isopropyl-4h-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide
11. Unii-ns3988a2tc
12. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-(6-(4-(propan-2-yl)-4h-1,2,4-triazol-3-yl)pyridin-2-yl)benzamide
13. Njv
14. Selonsertibgs-4997
15. Selonsertib [jan]
16. Gs-4997; Selonsertib
17. Selonsertib [usan:inn]
18. Selonsertib; Gs-4997
19. Selonsertib [usan]
20. Selonsertib (gs-4997)
21. Selonsertib [who-dd]
22. Selonsertib (jan/usan/inn)
23. C24h24fn7o
24. Gtpl9040
25. Chembl3916717
26. Schembl14672984
27. Amy27913
28. Bcp17814
29. Ex-a1150
30. Ex-a1618
31. Bdbm50212258
32. Gs4997
33. Mfcd29920355
34. Nsc797772
35. S8292
36. Akos027338646
37. Zinc149387856
38. Ccg-269184
39. Cs-5328
40. Db14916
41. Nsc-797772
42. Sb17466
43. Ncgc00479176-02
44. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-n-(6-(4-isopropyl-4h-1,2,4-triazol-3-yl)-2-pyridinyl)-4-methylbenzamide
45. Ac-31493
46. As-35035
47. Benzamide, 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-(6-(4-(1-methylethyl)-4h-1,2,4-triazol-3-yl)-2-pyridinyl)-
48. Hy-18938
49. Selonsertib Hcl Salt, Gs-4997 Hcl Salt
50. D10988
51. A857921
52. Gs-4997; Gs4997; Gs 4997
53. Q27088777
54. 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-[6-[4-(1-methylethyl)-4h-1,2,4-triazol-3-yl]-2-pyridinyl]benzamide
55. 5-(4-cyclopropyl-1h-imidazol-1-yl)-n-(6-(4-isopropyl-4h-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide
56. Benzamide, 5-(4-cyclopropyl-1h-imidazol-1-yl)-2-fluoro-4-methyl-n-(6-(4-(1-methylethyl)-4h-1,2,4-triazol-3-yl)-2-pyridinyl)
| Molecular Weight | 445.5 g/mol |
|---|---|
| Molecular Formula | C24H24FN7O |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 445.20263658 g/mol |
| Monoisotopic Mass | 445.20263658 g/mol |
| Topological Polar Surface Area | 90.5 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 692 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of non-alcoholic steatohepatitis (NASH)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Selonsertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Selonsertib, including repackagers and relabelers. The FDA regulates Selonsertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Selonsertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Selonsertib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Selonsertib supplier is an individual or a company that provides Selonsertib active pharmaceutical ingredient (API) or Selonsertib finished formulations upon request. The Selonsertib suppliers may include Selonsertib API manufacturers, exporters, distributors and traders.
click here to find a list of Selonsertib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Selonsertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Selonsertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Selonsertib GMP manufacturer or Selonsertib GMP API supplier for your needs.
A Selonsertib CoA (Certificate of Analysis) is a formal document that attests to Selonsertib's compliance with Selonsertib specifications and serves as a tool for batch-level quality control.
Selonsertib CoA mostly includes findings from lab analyses of a specific batch. For each Selonsertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Selonsertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Selonsertib EP), Selonsertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Selonsertib USP).
LOOKING FOR A SUPPLIER?
